diagnocure inc (CUR:Toronto)
diagnocure inc (CUR) Snapshot
|
Open
C$0.27
|
Previous Close
C$0.27
|
|
|
Day High
C$0.27
|
Day Low
C$0.27
|
|
|
52 Week High
06/27/12 - C$0.84
|
52 Week Low
04/18/13 - C$0.20
|
|
|
Market Cap
11.4M
|
Average Volume 10 Days
17.8K
|
|
|
EPS TTM
C$-0.07
|
Shares Outstanding
43.0M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
diagnocure inc (CUR) Related Businessweek News
No Related Businessweek News Founddiagnocure inc (CUR) Details
DiagnoCure, Inc., a life sciences company, engages in the development and commercialization of cancer diagnostic tests for the detection and management of cancer. The company primarily focuses on molecular diagnostic tests. It has granted a worldwide exclusive license agreement to Gen-Probe for the development and commercialization of a prostate cancer test using PCA3. The company was founded in 1994 and is headquartered in Quebec, Canada.
diagnocure inc (CUR) Top Compensated Officers
diagnocure inc (CUR) Key Developments
To update on the Corporation's current status of the GCC and PCA3 products, review of the Corporation's business model evolution; Initiation of a search for a full-time CEO to achieve maximum leverage from DiagnoCure's product development platform
DiagnoCure Inc. announced that at the AGM held on April 29, 2013, the shareholders approved and ratified amendments to the articles of DiagnoCure, approved and ratified the new by-laws of the company - including the advanced notice by-law, and approved all unallocated options under DiagnoCure's stock option plan.
The Annual General Meeting of the shareholders of DiagnoCure Inc. to be held on April 29, 2013. At the meeting shareholders to consider and, if deemed advisable, to adopt a special resolution for the purpose of amending the articles of the corporation, all as more particularly described in the accompanying management proxy circular of the corporation.
| Recently Viewed | |||
| CUR:CN | C$0.27 CAD | -0.005 |  |
| Company | Last | Change |
| Health Discovery Corp | $0.05 USD | 0.00 |
| Imperial Innovations Group PLC | 284.00 GBp | +1.50 |
| MDxHealth | €2.05 EUR | +0.05 |
| Miraculins Inc | C$0.07 CAD | 0.00 |
| Myriad Genetics Inc | $32.93 USD | -0.08 |
| View Industry Companies | ||
Industry Analysis
CUR
Industry Average
| Valuation | CUR | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 5.8x |
|
| Price/Book | 3.2x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 0.6x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Northglenn, CO | Office DepotPosted: Mar 01
Sponsored Financial Commentaries
Sponsored Links
To contact DIAGNOCURE INC, please visit www.diagnocure.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
